期刊文献+

LP-PLA2在初诊断2型糖尿病微血管病变患者中的水平变化及相关性研究 被引量:2

Changes and Correlation of LP-PLA2 in Patients with Newly Diagnosed Type 2 Diabetic Microangiopathy
下载PDF
导出
摘要 目的探讨LP-PLA2在初诊断2型糖尿病微血管病变患者中的水平变化及相关性。方法选取泰州市人民医院内分泌科2020年1月至2021年1月住院或门诊初次诊断的糖尿病患者156例(糖尿病组),按照有无糖尿病性微血管病变分为非糖尿病性微血管病变组(A组),糖尿病性微血管病变组(B组),其中糖尿病性微血管病变组包括糖尿病性肾病和糖尿病性视网膜病变;选取14例健康体检者做对照为正常组(C组);分别检测脂蛋白相关磷脂酶A2 LP-PLA2指标外,同时测定体重指数,腰围、肝肾功能、血糖、血脂、空腹C肽、糖化血红蛋白、血清胱抑素、β2-微球蛋白、尿ACR等,分析LP-PLA2在初诊断2型糖尿病性微血管病变患者中的水平变化及相关性。结果糖尿病组患者LPPLA2水平较正常组相比有升高,差异有统计学意义(P<0.05);非糖尿病性微血管病变组(A组)与糖尿病性微血管病变组(B组)相比,LP-PLA2水平变化,差异有统计学意义(P<0.05);Logistic回归分析提示胱抑素C、LP-PLA2、病程为糖尿病微血管病变发生的危险因素,高密度脂蛋白胆固醇为保护因素。结论LP-PLA2检测在早期糖尿病性微血管病变诊断中有重要意义。 Objective To investigate Changes and correlation of LP-PLA2 in patients with newly diagnosed type 2 diabetic microangiopathy.Methods Totally 156 cases of patients with type 2 diabetes mellitus who were treated in Department of Endocrinology from January 2020 to January 2021,were selected as the research objects,and were divided into non-diabetic microangiopathy group(Group A)and diabetic microangiopathy group(Group B),in which diabetic microangiopathy group included diabetic nephropathy and diabetic retinopathy.According to the presence or absence of diabetic microangiopathy,14 healthy subjects were selected as control group(Group C).Then,the body mass index(BMI),waist circumference,liver and kidney function,blood glucose,blood lipid,LP-PLA2,LP-PLA2,fasting C peptide,glycated hemoglobin,serum Cystatin,β2-microglobulin,urinary ACR and other clinical data of three groups of patients were codirected and compared.Results The level of LP-PLA2 in diabetic group was significantly higher than that in normal group(P<0.05),the level of LPPLA2 in non-diabetic microangiopathy group(Group A)was significantly higher than that in diabetic microangiopathy group(Group B),the difference was statistically significant(P<0.05).Logistic Regression analysis showed that Cystatin C,LP-PLA2,course of disease,and HDL were associated with diabetic microangiopathy.Conclusion The detection of LP-PLA2 has important significance in the early diagnosis of diabetic microangiopathy.
作者 葛飞 杨淑芳 刘恩琳 杨明月 李湘怡 范苇苇 GE Fei;YANG Shu-fang;LIU En-lin;YANG Ming-yue;LI Xiang-yi;FAN Wei-wei(No.5 Hospital Affiliated to Nantong University(Taizhou People's Hospital);Postgraduate Training Base of Dalian Medical University(Taizhou People's Hospital),Taizhou Jiangsu 225300,China)
出处 《泰州职业技术学院学报》 2022年第3期75-78,共4页 Journal of Taizhou Polytechnic College
基金 南通大学临床医学专项科研项目(2019LY009,项目主持人:杨淑芳).
关键词 2型糖尿病 脂蛋白相关磷脂酶A2 糖尿病微血管病变 type 2 diabetes lipoprotein-associated Phospholipase A2 diabetic microangiopathy
  • 相关文献

参考文献8

二级参考文献33

  • 1中华医学会内分泌学分会.中国成人2型糖尿病预防的专家共识[J].中华内分泌代谢杂志,2014,30(4). 被引量:165
  • 2CAMERON N E, EATON S E M, COTTER M A, et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy [J]. Diabetologia,2001,44 ( 11 ) : 1973 - 1988.
  • 3ZIEGLER D,SIEKIERKA K E, MEYER B, et al. Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy [J ]. Diabetes Care, 2005,28(5 ) : 1169 - 1174.
  • 4WU E Q, BORTON J, SAID G, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France[ J ]. Current Medical Research and Opinion, 2007,23 (9) :2035 - 2042.
  • 5MEIJER J W, BOSMA E,LEFRANDT J D,et al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores[J]. Diabetes Care,2003,26(3):697 - 701.
  • 6PERKINS B A,OLALEYE D,ZINMAN B,et al. Simple screening tests for peripheral neuropathy in the diabetes clinic [J]. Diabetes Care,2001,24(2) :250 - 256.
  • 7LEONARD D R, FA ROOQI M H, MYERS S,et al. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral [J]. Neuropathy Diabetes Care,2004,27( 1 ) : 168 - 172.
  • 8HAYASE F, MATSUURA H, SANADA M, et al. Inhibitory action of protein kinase C beta inhibitor on tetrodotoxin-resistant Na^+ current in small dorsal root ganglion neurons in diabetic rats [J]. Neurosci Lett,2007,417 (1):90-94.
  • 9BITAR M S,WAHID S,MUSTAFA S,et al. Nitric oxide dynamics and endothelial dysfunction in type Ⅱ model of genetic diabetese [ J ]. Eur J Pharmacol, 2005,511 ( 1 ) : 53 - 64.
  • 10INOGUCHI T,TSUBOUCHI H, ETOH T,et al. A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD (P)H oxidase [ J ]. Curr Med Chem, 2003,10( 17 ) : 1759 - 1764.

共引文献58

同被引文献28

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部